Researchers developed a single LRS assay that can detect and characterize genetic variations causing inherited myopathies, ...
Higher CD34+ cell and colony-forming unit-granulocyte/macrophage (CFU-GM) doses were associated with better DFS in high-risk ...
The FDA has approved an update to the label of sotatercept-csrk to include data from a trial, which tested the drug in newly ...
The results of a retrospective study of patients with Gaucher disease (GD) type 1 may support earlier screening for Parkinson ...
Interstitial lung abnormalities have an adverse effect on long-term survival after non–small cell lung cancer resection, ...
Switching from emicizumab to denecimig without a washout period in adolescents and adults with hemophilia A is well tolerated ...
RBCs in patients with low-risk MDS carry distinct physiological abnormalities that go beyond ineffective erythropoiesis.
The results of a new study show miR-196a may reduce mHTT through Rad23b, suggesting the protein as a potential target in HD.
CAR T-cell therapy produced a 68% overall response rate in 194 patients with PCNSL, but progression-free survival fell to 25% ...
HPS has 11 subtypes; 100% of patients with type 1, 2, or 4 will develop pulmonary fibrosis, usually by their mid-30s.
The permeability of the blood-brain barrier is increased in young adults with SCD and is associated with microstructural ...
Hypomethylating agents significantly improve overall survival rates of patients in Thailand with high-risk MDS, a study found ...